Brief: Chromogenics Q2 EBITDA Loss Narrows To SEK 13.9 Million
25/08/2022 07:41
Aug 25 (Reuters) - ChromoGenics AB CHRO.ST :
* Q2 NET SALES SEK 2.8 MILLION VERSUS SEK 1.7 MILLION YEAR
AGO
* Q2 EBITDA LOSS SEK 13.9 MILLION VERSUS LOSS SEK 28.3
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrFlSGY
Further company coverage: CHRO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChromoGenics AB
See all newsBrief: Chromogenics Says Conditional Loan Of SEK 47.6 Mln Is Converted To Grant
Brief: Färna Invest Makes SEK 10/Shr Offer For Chromogenics
Brief: Chromogenics Q1 Pre-Tax Loss Widens To SEK 13.6 Mln
Brief: Chromogenics Gets First Order For North America
Brief: Chromogenics Initiates Cost Reduction Program